Please login to the form below

Not currently logged in

FDA panel backs Novartis' secukinumab for psoriasis

Novartis building

Drug has outperformed Amgen’s Enbrel in clinical trials

AbbVie and Shire bring merger plans to a close

shire abbvie logosBlames tax changes in the US

EMA offers orphan drug benefits for Ebola research

European Medicines Agency (EMA)Incentives to encourage development of new treatments for the virus

Janssen's blood cancer drug Imbruvica approved in Europe

JanssenEuropean commission licenses the first-in-class drug for two rare diseases

Regeneron top science employer, says survey

Ranked highest for third year in a row

FDA votes to keep severe warning on Pfizer’s Chantix

FDA headquarters White OakWill not relax anti-smoking drug's side effect warning

Amgen files lawsuit to block PCSK9 rivals

Amgen flagFirm suing Sanofi and Regeneron for patent infringement

AbbVie teams up with charities to raise awareness of bronchiolitis

more than a coldMost common cause of infant hospital admissions in winter

Baxter to launch HyQvia in US next week

Baxter buildingThe PID drug has been used in Europe for over a year

Fast and Slow ThinkingChanging behaviour with fast and slow thinking

Challenging the decision-making that underpins behaviour change

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, market access, healthcare digital excellence, and strategic consultancy. We bring...

Latest intelligence

Online Physician Communities
M3 and partners win Digital Sales Aid Award
Wins for campaign to overcome limited doctor engagement with pharma-owned websites...
UK Customer Experience Awards 2014 Highlights
Stephanie Hall, Managing Director at Uptake Strategies, attended this year’s cross-industry UK Customer Experience Awards as a member of the judging panel for Business Transformation....
The heart of the matter - Part Three
Is pharma doing enough to maximise real world evidence?...